![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Syneos Health Inc | NASDAQ:SYNH | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 42.98 | 42.96 | 42.99 | 0 | 01:00:00 |
“At Syneos Health, we’re committed to developing women leaders and exceptional talent,” said Alistair Macdonald, Chief Executive Officer, Syneos Health. “We’re thrilled that two of the brightest solutions-oriented leaders in our business are being recognized alongside the best in the biopharmaceutical industry.”
HBA is a global nonprofit organization comprised of individuals and organizations from across the healthcare industry committed to furthering the advancement and impact of women in the business of healthcare. Each year the organization celebrates women leaders across the life sciences industry through their “Luminary” and “Rising Star” award program at the WOTY luncheon.
Syneos Health leaders will be recognized this year in both the Luminary and Rising Star categories.
“Amy and Kellie embody a collaborative spirit that Syneos Health brings forth to solve some of our customer’s biggest challenges. These women work across their teams and across disciplines unlocking creativity, innovation and new solutions for our customers,” said Lisa van Capelle, Chief Human Resources Officer, Syneos Health. To further the discussion around the importance of women’s leadership in the life sciences industry, the Syneos Health Communications office in London is hosting a live feed of the WOTY luncheon, followed by a panel discussion focused on leveraging cross-sector experience to transform life sciences.
Syneos Health has been a member of the HBA for 17 years, supporting employees’ access to local and national professional development, mentoring and career boosting tools. About Syneos HealthSyneos Health (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. Created through the merger of two industry leading companies – INC Research and inVentiv Health – we bring together more than 21,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. To learn more about how we are shortening the distance from lab to life® visit syneoshealth.com.
Contact: | ||||
Investor Relations Contact: | Press/Media Contact: | |||
Ronnie Speight | Danielle DeForge | |||
Vice President, Investor Relations | Senior Director, External Communications | |||
+1 919 745 2745 | +1 202 210 5992 | |||
Investor.Relations@syneoshealth.com | danielle.deforge@syneoshealth.com |
1 Year Syneos Health Chart |
1 Month Syneos Health Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions